^^ 2023 December
^^ 2024 March
^^ 2024 June
^^ 2024 September
The March quarter showed the "delayed selling revenue" from the US initial market launch as quoted by Paul and Doug. They missed half the season.
By that logic, if they didn't miss half the season and had a full season, you could suggest double the revenue which would place it at $1.4Million projected.
So Hawks logic of $2million isn't some arbitrary number.
Since that quarter also, they have signed on Medigroup, Thermo Fisher, HS Australia, NZ, Belgium etc.
Mate, if they cant crack near $2Million for the current season, there are major problems / questions. Just because they put onus on the distributor to market and sell, doesn't mean Lumos direct eases of the gas pedal. They should be actively trying to sell direct themselves to users for a higher profit margin and increased revenue.
It isn't down ramping. Its embarrassing.
Add to My Watchlist
What is My Watchlist?
